December 15, 2009 – CE Mark approval has been granted for Pathway Medical Technologies’ Jetstream G2TM NXT System, a peripheral atherectomy catheter for use in the treatment of PAD.
December 15, 2009 - The European Medicines Agency (EMEA) recently approved a new indication for Procoralan (ivabradine) for chronic, stable angina patients, who remain inadequately controlled despite an optimal dose of beta blockers, and whose heart rate is above 60 beats per minute.
December 14, 2009 – A new drug application (NDA) was recently submitted to the U.S. Food and Drug Administration (FDA) for ticagrelor, an investigational oral anti-platelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndrome (ACS).
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
December, 14, 2009 – A supplemental new drug application (sNDA) has been submitted to the U.S. Food and Drug Administration (FDA) for two new dosage strengths of SIMCOR, a cholesterol medication.
December 14, 2009 – First new anti-arrhythmic drug to be approved in the European Union in the last 10 years was recently granted European Commission marketing authorization.
December 14, 2009 – For its unique Return to Work Lab, which focuses on individualized rehabilitation for younger, more active cardiac patients, the Baylor Jack and Jane Hamilton Heart and Vascular Hospital in north Texas recently received an award.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
December 11, 2009 – At this year’s Radiology Society of America (RSNA) annual meeting last week, GE Healthcare, presented the new Innova dose-efficient X-ray technology to reduce patient radiation exposure.
December 11, 2009 – A new nonlinear algorithm has been selected for a month-long April 2010 noninvasive cardiac screening of teenagers in danger of sudden cardiac death in south east London. Vicor Technologies Inc. said its PD2i nonlinear algorithm will be used along with ECG and echocardiogram to identify those at risk.
December 10, 2009 – European approval was recently granted for the use of Angiox (bivalirudin) as an anti-coagulant in patients with ST-segment elevated myocardial infarction (STEMI) who undergoing emergency primary percutaneous coronary intervention (PCI).
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 10, 2009 – An exclusive license agreement between On-X Life Technologies and the Cleveland Clinic will create a system of products intended to improve and simplify the replacement of damaged or severed mitral valve chordae. The system is the creation of co-inventors A. Marc Gillinov, M.D., a staff cardiac surgeon at Cleveland Clinic, and Michael K.
December 9, 2009 — A new cardiovascular care system was previewed during the recent Medica exhibition in Germany. The system, slated for a 2010 launch, provides clinical decision support for cardiovascular care of critically ill patients.
December 9, 2009 — A feasibility clinical trial was launched last week to evaluate the safety and efficacy of a combined surgical and catheter procedure, the convergent procedure, for the treatment of symptomatic paroxysmal atrial fibrillation (AF).
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
December 9, 2009 - An expert panel reviewing Canadian medical isotope productions selected electron beam technology as a superior approach to accelerator-based isotope production. The panel has recommended the Canadian government make an investment in linear accelerator (linac) technology to address the country’s shrinking isotope supply.
December 8, 2009 – New findings indicate reduced heart rate recovery in combination with heightened T-wave alternans is a powerful predictor of cardiovascular and all-cause death in low-risk populations.
December 9, 2009 – Of the 1,200 cardiologists and cardiovascular ultrasound technicians recently surveyed, 87 percent said the new 2010 CMS Physician Fee Schedule (PFS) could force them to stop accepting Medicare patients, reduce staff or shut down their practice completely.